Biopharmaceutical Third Party Logistics (3PL) Market Report by Supply Chain (Cold Chain, Non-Cold Chain), Service Type (Transportation, Warehousing and Storage, and Others), and Region 2024-2032

Biopharmaceutical Third Party Logistics (3PL) Market Report by Supply Chain (Cold Chain, Non-Cold Chain), Service Type (Transportation, Warehousing and Storage, and Others), and Region 2024-2032

Report Format: PDF+Excel | Report ID: SR112024A3662
Buy Now

Biopharmaceutical Third Party Logistics (3PL) Market Overview:

The global biopharmaceutical third party logistics (3PL) market size reached US$ 123.0 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 195.4 Billion by 2032, exhibiting a growth rate (CAGR) of 5.2% during 2024-2032.

Report Attribute 
Key Statistics
Base Year
2023
Forecast Years
2024-2032
Historical Years
2018-2023
Market Size in 2023
US$ 123.0 Billion
Market Forecast in 2032
US$ 195.4 Billion
Market Growth Rate 2024-2032 5.2%


Biopharmaceutical third-party logistics (3PL) refer to the services outsourced by pharmaceutical companies through third-party organizations. It involves receiving small molecule drugs, vaccines, biologics and other medical products into the warehouse, fulfilling orders and handling inventory of the goods through a warehouse management system. 3PL assists pharma and medical institutions in maintaining the logistics for delivering medical therapies, reducing medicine prices by minimizing wasteful overhead expenses, ensuring uninterrupted product supply, improving transportation services and enhancing the overall efficiencies of the organization.

Biopharmaceutical Third Party Logistics (3PL) Market

Biopharmaceutical Third Party Logistics (3PL) Market Trends:

Significant growth in the pharmaceutical industries is one of the key factors creating a positive outlook for the market. Furthermore, the emerging trend of outsourcing logistics by various medical organizations to optimize their distribution network is providing a thrust to the market growth. As the coronavirus disease (COVID-19) continues to spread across the globe, there has been a significant increase in the demand for 3PL logistics to minimize drug supply disruptions and prioritize the availability of critical care drugs. Various technological advancements, such as the launch of warehouse robotics, mobile cloud computing, real-time monitoring and data mining solutions, are acting as other growth-inducing factors. These technologies aid in automating logistics-related processes and minimizing operation complexities, human errors and damages caused to the products in transit. In line with this, near field communication (NFC) and internet of thing (IoT)-based cold chain monitoring products are also being used to manage temperature-sensitive pharmaceutical products and get real-time updates and alerts regarding the shipments.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global biopharmaceutical third party logistics (3PL) market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on supply chain and service type.

Breakup by Supply Chain:

  • Cold Chain
  • Non-Cold Chain
     

Breakup by Service Type:

  • Transportation
    • Air Freight
    • Sea Freight
    • Overland
  • Warehousing and Storage
  • Others
     

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa
     

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Agility Logistics, AmerisourceBergen Corporation, DB Schenker (Deutsche Bahn), DHL International GmbH (Deutsche Post), FedEx Corporation, Kerry Logistics Network Limited, Kuehne + Nagel International AG, McKesson Corporation, SF Express Co. Ltd. and United Parcel Service of America Inc.

Report Coverage:

Report Features Details
Base Year of the Analysis 2023
Historical Period 2018-2023
Forecast Period 2024-2032
Units US$ Billion
Segment Coverage Supply Chain, Service Type, Region
Region Covered  Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Countries Covered United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
Companies Covered Agility Logistics, AmerisourceBergen Corporation, DB Schenker (Deutsche Bahn), DHL International GmbH (Deutsche Post), FedEx Corporation, Kerry Logistics Network Limited, Kuehne + Nagel International AG, McKesson Corporation, SF Express Co. Ltd. and United Parcel Service of America Inc.
Customization Scope 10% Free Customization
Report Price and Purchase Option Single User License: US$ 3899
Five User License: US$ 4899
Corporate License: US$ 5899
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

Key Questions Answered in This Report

According to the estimates by IMARC Group, the global biopharmaceutical third party logistics (3PL) market is expected to grow at a CAGR of 5.2% during 2024-2032.

The increasing adoption of outsourced logistics services by various medical organizations to optimize their distribution network represents one of the key drivers for the global biopharmaceutical third party logistics (3PL) market.

The rising integration of 3PL services with warehouse robotics, mobile cloud computing, real-time monitoring, and data mining solutions, represents one of the key trends in the global biopharmaceutical third party logistics (3PL) market.

Sudden outbreak of the COVID-19 pandemic had led to a significant increase in the demand for 3PL logistics to minimize drug supply disruptions and prioritize the availability of critical care drugs.

On the basis of the supply chain, the market has been divided into cold chain and non-cold chain. Among these, non-cold chain represents the largest segment.

On the basis of the service type, the market has been bifurcated into transportation, warehousing and storage, and others. Currently, warehousing and storage holds the majority of the total market share.

Region-wise, the market has been classified into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America, where North America dominates the global market.

The key companies in the global biopharmaceutical third party logistics (3PL) market are Agility Logistics, AmerisourceBergen Corporation, DB Schenker (Deutsche Bahn), DHL International GmbH (Deutsche Post), FedEx Corporation, Kerry Logistics Network Limited, Kuehne + Nagel International AG, McKesson Corporation, SF Express Co. Ltd., and United Parcel Service of America Inc.

Need more help?

  • Speak to our experienced analysts for insights on the current market scenarios.
  • Include additional segments and countries to customize the report as per your requirement.
  • Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  • For further assistance, please connect with our analysts.
Biopharmaceutical Third Party Logistics (3PL) Market Report by Supply Chain (Cold Chain, Non-Cold Chain), Service Type (Transportation, Warehousing and Storage, and Others), and Region 2024-2032
Purchase options




Benefits of Customization

Personalize this research

Triangulate with your data

Get data as per your format and definition

Gain a deeper dive into a specific application, geography, customer, or competitor

Any level of personalization

Get in Touch With Us
UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-713-2163

Email: sales@imarcgroup.com

Client Testimonials

Aktive Services

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

Read More
Greenfish S.A.

The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required

Read More
Colruyt Group

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Read More
KRISHAK BHARTI CO-OP LTD

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

Read More
Zee Media Corp. Ltd.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Read More
Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

Read More
Sumitomo Corporation

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

Read More
Hameln Rds

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

Read More
Quality Consultants BV

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

Read More
TATA Advanced Systems Limited

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

Read More
Stax

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.

Read More